Enhancement of chemosensitivity by tyrphostin AG825 in high-p185^neu expressing non-small cell lung cancer cells

Keyphrases

• Non-small Cell Lung Cancer Cells 100%
• Tyrphostin 100%
• Chemosensitivity 100%
• Drug-induced 80%
• Human Lung Cancer Cell Line 60%
• Differential Effects 40%
• Human Epidermal Growth Factor Receptor 2 (HER2) 40%
• G2 Arrest 40%
• Phosphorylation State 20%
• Tyrosine Kinase Inhibitor 20%
• Membrane Receptors 20%
• Anticancer Agents 20%
• High Concentration 20%
• Tyrosine Kinase Activity 20%
• Gene Products 20%
• Clinical Trials 20%
• Antagonistic Effect 20%
• Etoposide 20%
• Cis-diamminedichloroplatinum 20%
• Intrinsic Chemoresistance 20%

Medicine and Dentistry

• Cancer Cell 100%
• Non Small Cell Lung Cancer 100%
• Chemosensitivity 100%
• 5 (2 Benzothiazolyl)thiomethyl 4 Hydroxy 3 Methoxybenzylidenecyanoacetamide 100%
• Cell Line 50%
• Lung Cancer Cell Line 37%
• Cell Cycle 25%
• G2 Phase Cell Cycle Checkpoint 25%
• Drug Resistance 12%
• Receptor 12%
• Phosphotransferase 12%
• Clinical Trial 12%
• Protein Tyrosine Kinase 12%
• Gene Product 12%
• Tyrphostin 12%
• Tyrosine-Kinase Inhibitor 12%
• Cisplatin 12%
• Etoposide 12%
• Anticancer Drug 12%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Chemosensitivity 100%
• Cell Cycle 40%
• G2 Phase Cell Cycle Checkpoint 40%
• Phosphotransferase 20%
• Kinase 20%
• Anticancer 20%
• Drug Resistance 20%
• Receptor Tyrosine Kinase 20%
• Tyrosine Kinase 20%
• Gene Product 20%
• Clinical Trial 20%
• Tyrosine Kinase Inhibitor 20%